SOTERA HEALTH COMPANY
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.4M | $280.0M | $303.4M | $311.3M | $294.3M | $254.5M | $290.2M | $285.5M |
| Cost of Revenue | $143.4M | $133.0M | $137.5M | $133.8M | $127.7M | $119.1M | $125.8M | $127.4M |
| Gross Profit | $178.0M | $147.1M | $165.9M | $177.6M | $166.6M | $135.4M | $164.4M | $158.0M |
| Gross Margin | 55.4% | 52.5% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $68.2M | $68.2M | $57.5M | $63.3M | $68.9M | $63.1M | $61.8M | $62.0M |
| Operating Income | $78.1M | $42.6M | $70.5M | $72.9M | $18.9M | $-14.8M | $87.1M | $80.5M |
| Operating Margin | 24.3% | 15.2% | 23.2% | 23.4% | 6.4% | -5.8% | 30.0% | 28.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $78.1M | $42.6M | $70.5M | $72.9M | $18.9M | $-14.8M | $45.0M | $42.8M |
| Income Tax Expense | $24.4M | $16.0M | $35.7M | $24.5M | $10.9M | $-1.6M | $32.6M | $25.8M |
| Net Income | $53.6M | $26.6M | $34.8M | $48.4M | $8.0M | $-13.3M | $12.3M | $17.0M |
| Net Margin | 16.7% | 9.5% | 11.5% | 15.5% | 2.7% | -5.2% | 4.2% | 6.0% |
| EPS (Basic) | $0.19 | $0.09 | $0.12 | $0.17 | $0.03 | $-0.05 | $0.05 | $0.06 |
| EPS (Diluted) | $0.19 | $0.09 | $0.12 | $0.17 | $0.03 | $-0.05 | $0.05 | $0.06 |
| Shares Outstanding (Basic) | 285.8M | 284.9M | 284.0M | 284.1M | 283.9M | 283.6M | 282.8M | 283.1M |
| Shares Outstanding (Diluted) | 288.1M | 287.6M | 286.4M | 286.7M | 285.8M | 283.6M | 284.9M | 285.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |